Hasil Pencarian - Peter Ferenci
- Menampilkan 1 - 15 hasil dari 15
-
1
Are the new genetic tools for diagnosis of Wilson disease helpful in clinical practice?Key points oleh Carmen Espinós, Peter Ferenci
Diterbitkan 2020-08-01
Artikel -
2
Treatment of Chronic Hepatitis D with Bulevirtide—A Fight against Two Foes—An Update oleh Peter Ferenci, Thomas Reiberger, Mathias Jachs
Diterbitkan 2022-11-01
Artikel -
3
-
4
-
5
Real-Time PCR Assays for the Quantification of HCV RNA: Concordance, Discrepancies and Implications for Response Guided Therapy. oleh Robert Strassl, Karoline Rutter, Albert Friedrich Stättermayer, Sandra Beinhardt, Michael Kammer, Harald Hofer, Peter Ferenci, Theresia Popow-Kraupp
Diterbitkan 2015-01-01
Artikel -
6
IL28B polymorphism cannot predict response to interferon alpha treatment in patients with melanoma. oleh Martin Probst, Christoph Hoeller, Peter Ferenci, Albert F Staettermayer, Sandra Beinhardt, Hubert Pehamberger, Harald Kittler, Katharina Grabmeier-Pfistershammer
Diterbitkan 2014-01-01
Artikel -
7
HSD17B13 truncated variant is associated with a mild hepatic phenotype in Wilson’s Disease oleh Peter Ferenci, Jan Pfeiffenberger, Albert Friedrich Stättermayer, Rudolf E. Stauber, Claudia Willheim, Karl H. Weiss, Petra Munda-Steindl, Michael Trauner, Michael Schilsky, Heinz Zoller
Diterbitkan 2019-05-01
Artikel -
8
Long-term follow-up of patients discontinuing bulevirtide treatment upon long-term HDV-RNA suppression oleh Mathias Jachs, Marlene Panzer, Lukas Hartl, Michael Schwarz, Lorenz Balcar, Jeremy V. Camp, Petra Munda, Mattias Mandorfer, Michael Trauner, Stephan W. Aberle, Heinz Zoller, Thomas Reiberger, Peter Ferenci
Diterbitkan 2023-08-01
Artikel -
9
Impact of Safety-Related Dose Reductions or Discontinuations on Sustained Virologic Response in HCV-Infected Patients: Results from the GUARD-C Cohort. oleh Graham R Foster, Carmine Coppola, Moutaz Derbala, Peter Ferenci, Alessandra Orlandini, K Rajender Reddy, Ludovico Tallarico, Mitchell L Shiffman, Silke Ahlers, Georgios Bakalos, Tarek Hassanein, GUARD-C Study Group
Diterbitkan 2016-01-01
Artikel -
10
The Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV Coinfection. oleh Bernhard Scheiner, Mattias Mandorfer, Philipp Schwabl, Berit Anna Payer, Theresa Bucsics, Simona Bota, Maximilian C Aichelburg, Katharina Grabmeier-Pfistershammer, Albert Stättermayer, Peter Ferenci, Michael Trauner, Markus Peck-Radosavljevic, Thomas Reiberger
Diterbitkan 2015-01-01
Artikel -
11
Alpha-1 antitrypsin Pi∗Z allele is an independent risk factor for liver transplantation and death in patients with advanced chronic liver disease oleh Lorenz Balcar, Bernhard Scheiner, Markus Urheu, Patrick Weinberger, Rafael Paternostro, Benedikt Simbrunner, Lukas Hartl, Mathias Jachs, David Bauer, Georg Semmler, Claudia Willheim, Matthias Pinter, Peter Ferenci, Michael Trauner, Thomas Reiberger, Albert Friedrich Stättermayer, Mattias Mandorfer
Diterbitkan 2022-11-01
Artikel -
12
Balapiravir plus peginterferon alfa-2a (40KD)/ribavirin in a randomized trial of hepatitis C genotype 1 patients(♦♦ Grant Support: This study was funded by Roche. The sponsor contr... oleh David R. Nelson, Stefan Zeuzem, Pietro Andreone, Peter Ferenci, Robert Herring, Donald M. Jensen, Patrick Marcellin, Paul J. Pockros, Maribel Rodríguez-Torres, Lorenzo Rossaro, Vinod K. Rustgi, Thomas Sepe, Mark Sulkowski, Isaac R. Thomason, Eric M. Yoshida, Anna Chan, George Hill
Diterbitkan 2012-01-01
Artikel -
13
Simeprevir with peginterferon α-2a/ribavirin for chronic hepatitis C virus genotype 1 infection in treatment-experienced patients: an open-label, rollover study oleh Edward J. Gane, Edwin DeJesus, Ewa Janczewska, Jacob George, Moises Diago, Mariliza Hendrique Da Silva, Henk Reesink, Igor Nikitin, Holger Hinrichsen, Stefan Bourgeois, Peter Ferenci, Umesh Shukla, Ronald Kalmeijer, Oliver Lenz, Bart Fevery, Chris Corbett, Maria Beumont, Wolfgang Jessner
Diterbitkan 2017-06-01
Artikel -
14
Synonymous mutation in adenosine triphosphatase copper‐transporting beta causes enhanced exon skipping in Wilson disease oleh Marlene Panzer, André Viveiros, Benedikt Schaefer, Nadja Baumgartner, Klaus Seppi, Atbin Djamshidian, Theodor Todorov, William J. H. Griffiths, Eckart Schott, Markus Schuelke, Dennis Eurich, Albert Friedrich Stättermayer, Adrian Bomford, Pierre Foskett, Julia Vodopiutz, Rudolf Stauber, Elke Pertler, Bernhard Morell, Herbert Tilg, Thomas Müller, Stefan Kiechl, Raul Jimenez‐Heredia, Karl Heinz Weiss, Si Houn Hahn, Andreas Janecke, Peter Ferenci, Heinz Zoller
Diterbitkan 2022-07-01
Artikel -
15
Faldaprevir, pegylated interferon, and ribavirin for treatment-naïve HCV genotype-1: pooled analysis of two phase 3 trials oleh Donald M. Jensen, Tarik Asselah, Douglas Dieterich, Graham R. Foster, Mark S. Sulkowski, Stefan Zeuzem, Parvez Mantry, Eric M. Yoshida, Christophe Moreno, Denis Ouzan, Mark Wright, Luis E. Morano, Robert Buynak, Marc Bourlière, Tarek Hassanein, Shuhei Nishiguchi, Jia-Horng Kao, Masao Omata, Seung W. Paik, David K. Wong, Edward Tam, Kelly Kaita, S. Victor Feinman, Jerry O. Stern, Joseph Scherer, Anne-Marie Quinson, Florian Voss, John-Paul Gallivan, Wulf O. Böcher, Peter Ferenci
Diterbitkan 2016-05-01
Artikel